SEI Investments’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $192M | Buy |
884,601
+65,445
| +8% | +$14.5M | 0.18% | 103 |
|
|
2025
Q4 | $187M | Sell |
819,156
-27,052
| -3% | -$6.16M | 0.18% | 95 |
|
|
2025
Q3 | $196M | Buy |
846,208
+157,456
| +23% | +$32.1M | 0.21% | 74 |
|
|
2025
Q2 | $128M | Buy |
688,752
+97,114
| +16% | +$18M | 0.15% | 140 |
|
|
2025
Q1 | $124M | Buy |
591,638
+174,852
| +42% | +$34M | 0.16% | 129 |
|
|
2024
Q4 | $74.1M | Sell |
416,786
-4,206
| -1% | -$773K | 0.1% | 222 |
|
|
2024
Q3 | $83.1M | Sell |
420,992
-63,287
| -13% | -$11.8M | 0.11% | 199 |
|
|
2024
Q2 | $83.1M | Buy |
484,279
+48,722
| +11% | +$8.07M | 0.12% | 169 |
|
|
2024
Q1 | $79.3M | Sell |
435,557
-29,481
| -6% | -$5.08M | 0.12% | 183 |
|
|
2023
Q4 | $72.1M | Buy |
465,038
+25,042
| +6% | +$3.65M | 0.12% | 178 |
|
|
2023
Q3 | $65.6M | Buy |
439,996
+12,096
| +3% | +$1.78M | 0.12% | 156 |
|
|
2023
Q2 | $57.7M | Sell |
427,900
-47,989
| -10% | -$7.04M | 0.1% | 198 |
|
|
2023
Q1 | $75.8M | Buy |
475,889
+20,047
| +4% | +$3.06M | 0.14% | 129 |
|
|
2022
Q4 | $73.7M | Sell |
455,842
-22,070
| -5% | -$3.38M | 0.16% | 114 |
|
|
2022
Q3 | $64.1M | Sell |
477,912
-49,953
| -9% | -$7.17M | 0.14% | 120 |
|
|
2022
Q2 | $80.9M | Buy |
527,865
+39,977
| +8% | +$6.11M | 0.17% | 96 |
|
|
2022
Q1 | $79M | Sell |
487,888
-30,915
| -6% | -$4.49M | 0.16% | 115 |
|
|
2021
Q4 | $70.2M | Buy |
518,803
+23,157
| +5% | +$2.74M | 0.13% | 154 |
|
|
2021
Q3 | $53.5M | Sell |
495,646
-218,491
| -31% | -$25M | 0.11% | 190 |
|
|
2021
Q2 | $80.4M | Buy |
714,137
+252,807
| +55% | +$28.5M | 0.18% | 104 |
|
|
2021
Q1 | $49.9M | Buy |
461,330
+8,840
| +2% | +$946K | 0.13% | 144 |
|
|
2020
Q4 | $48.5M | Sell |
452,490
-15,715
| -3% | -$1.51M | 0.13% | 154 |
|
|
2020
Q3 | $41.1M | Sell |
468,205
-112,652
| -19% | -$10.6M | 0.12% | 147 |
|
|
2020
Q2 | $57M | Buy |
580,857
+54,282
| +10% | +$4.78M | 0.18% | 100 |
|
|
2020
Q1 | $40.2M | Sell |
526,575
-56,309
| -10% | -$4.8M | 0.15% | 117 |
|
|
2019
Q4 | $51.6M | Buy |
582,884
+226,098
| +63% | +$18.8M | 0.15% | 116 |
|
|
2019
Q3 | $27.1M | Buy |
356,786
+185,333
| +108% | +$12.7M | 0.07% | 259 |
|
|
2019
Q2 | $12.5M | Sell |
171,453
-15,437
| -8% | -$1.21M | 0.04% | 476 |
|
|
2019
Q1 | $15.1M | Sell |
186,890
-145,656
| -44% | -$11.9M | 0.05% | 388 |
|
|
2018
Q4 | $31.2M | Buy |
332,546
+30,995
| +10% | +$2.73M | 0.11% | 182 |
|
|
2018
Q3 | $28.5M | Sell |
301,551
-183,082
| -38% | -$17.4M | 0.1% | 186 |
|
|
2018
Q2 | $44.9M | Buy |
484,633
+22,949
| +5% | +$2.24M | 0.15% | 123 |
|
|
2018
Q1 | $43.7M | Sell |
461,684
-45,654
| -9% | -$5.02M | 0.17% | 126 |
|
|
2017
Q4 | $49.1M | Buy |
507,338
+146,386
| +41% | +$13.8M | 0.17% | 119 |
|
|
2017
Q3 | $32.1M | Buy |
360,952
+92,459
| +34% | +$7.04M | 0.11% | 180 |
|
|
2017
Q2 | $19.5M | Buy |
268,493
+35,791
| +15% | +$2.41M | 0.08% | 301 |
|
|
2017
Q1 | $15.2M | Buy |
232,702
+14,231
| +7% | +$895K | 0.07% | 360 |
|
|
2016
Q4 | $13.7M | Buy |
218,471
+70,396
| +48% | +$4.3M | 0.07% | 379 |
|
|
2016
Q3 | $9.34M | Sell |
148,075
-3,560
| -2% | -$230K | 0.05% | 474 |
|
|
2016
Q2 | $9.39M | Sell |
151,635
-108,385
| -42% | -$6.6M | 0.06% | 423 |
|
|
2016
Q1 | $14.9M | Sell |
260,020
-22,240
| -8% | -$1.24M | 0.09% | 263 |
|
|
2015
Q4 | $16.7M | Buy |
282,260
+48,040
| +21% | +$2.77M | 0.1% | 250 |
|
|
2015
Q3 | $12.7M | Sell |
234,220
-13,551
| -5% | -$882K | 0.12% | 205 |
|
|
2015
Q2 | $16.6M | Sell |
247,771
-35,251
| -12% | -$2.3M | 0.15% | 161 |
|
|
2015
Q1 | $16.6M | Sell |
283,022
-456,207
| -62% | -$27.6M | 0.14% | 169 |
|
|
2014
Q4 | $48.4M | Buy |
+739,229
| New | +$46.6M | 0.43% | 39 |
|
Other funds holding ABBV
VCM
VPM
SEI Investments's ABBV Position: Q1 2026 in Review
SEI Investments increased its AbbVie (ABBV) stake by 8% in Q1 2026, buying an estimated $14.5M and bringing the position to 884,601 shares worth $192M. The position accounts for 0.18% of the portfolio, ranked #103.
SEI Investments first reported a position in ABBV in Q4 2014 and has held it in 46 quarters since. The position peaked at $196M in Q3 2025. 4,079 funds tracked by Wall St. Rank hold ABBV as of Q1 2026.
- SEI Investments held 884,601 shares of AbbVie worth $192M as of Q1 2026.
- SEI Investments bought 65,445 AbbVie shares in Q1 2026, an estimated $14.5M.
- AbbVie made up 0.18% of SEI Investments's portfolio in Q1 2026, its #103 holding.
- SEI Investments first reported a position in AbbVie in Q4 2014 and has held it in 46 quarters since.
- SEI Investments's AbbVie position peaked at $196M in Q3 2025.
- 4,079 funds tracked by Wall St. Rank held AbbVie as of Q1 2026.
Based on SEI Investments's 13F filing for Q1 2026, filed 13 May 2026.